Driving Automated Workflows & Accelerating Drug Development with AI-Powered Trials - with Michelle Longmire of Medable
Today’s guest is Michelle Longmire, Co-founder and CEO of Medable. Medable is a platform technology company that accelerates drug development by improving evidence generation in clinical trials. Michelle joins us on the show today to explore how AI is transforming the clinical trial experience for patients, sites, and sponsors from start to finish. Michelle also offers valuable advice on adopting a portfolio-level digital strategy and managing the organizational change required to embrace AI innovation in clinical research. This episode is sponsored by Medable. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.